The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability
Open accessAbstract
Pharmaceutical particle technology is employed to improve poor aqueous solubility of drug compounds that limits in vivo bioavailability owing to their low dissolution rate in the gastrointestinal fluids following oral administration. The particle technology involves several approaches from the conventional size reduction processes to the newer, novel particle technologies that modify the solubility properties of the drugs and produce solid, powdered form of the drugs that are readily soluble in water and can be easily formulated into various dosage forms. This review highlights the solid particle technologies available for improving solubility, dissolution and bioavailability of drugs with poor aqueous solubility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling and comparison of dissolution profiles
Costa, P., & Sousa Lobo, J. M. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00095-1 · Cited by 5,509
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Drug Solubility: Importance and Enhancement Techniques
Savjani, K. T., Gajjar, A. K., & Savjani, J. K. (2012) · ISRN Pharmaceutics · doi:10.5402/2012/195727 · Cited by 2,004
Cyclodextrins as pharmaceutical solubilizers
Brewster, M. E., & Loftsson, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.012 · Cited by 1,882
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Block copolymer micelles: preparation, characterization and application in drug delivery
Gaucher, G., Dufresne, M.-H., Sant, V. P., Kang, N., Maysinger, D., & Leroux, J.-C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.034 · Cited by 1,498
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates
Blagden, N., de Matas, M., Gavan, P. T., & York, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.011 · Cited by 1,448
Pouton, C. W. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.016 · Cited by 1,293
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,263
Polymeric micelles—A new generation of colloidal drug carriers
Jones, M.-C., & Leroux, J.-C. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00039-9 · Cited by 1,256
Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., & Onoue, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.032 · Cited by 1,181
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
KECK, C., & MULLER, R. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.05.009 · Cited by 1,061
Nanocrystal technology, drug delivery and clinical applications
Müller, R., & Junghanns (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s595 · Cited by 953
Liversidge, G. G., & Cundy, K. C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00122-y · Cited by 739
Dokoumetzidis, A., & Macheras, P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.011 · Cited by 715
Polymeric micelles as new drug carriers
Kwon, G. S., & Okano, T. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00401-2 · Cited by 710
Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API
McNamara, D. P., Childs, S. L., Giordano, J., Iarriccio, A., Cassidy, J., Shet, M. S., Mannion, R., O'Donnell, E., & Park, A. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9032-3 · Cited by 690
Lukyanov, A. N., & Torchilin, V. P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.004 · Cited by 655
Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions
Yu, L. X., Amidon, G. L., Polli, J. E., Zhao, H., Mehta, M. U., Conner, D. P., Shah, V. P., Lesko, L. J., Chen, M.-L., Lee, V. H. L., et al. (2002) · Pharmaceutical Research · doi:10.1023/a:1016473601633 · Cited by 571
Drug delivery strategies for poorly water-soluble drugs
Fahr, A., & Liu, X. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.403 · Cited by 568
The utility of cyclodextrins for enhancing oral bioavailability
Carrier, R. L., Miller, L. A., & Ahmed, I. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.07.018 · Cited by 557
Üner, M., & Yener, G. (2007) · PubMed Central · Cited by 543
Targeted polymeric micelles for delivery of poorly soluble drugs
Torchilin, V. P. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4153-5 · Cited by 543
Jinno, J.-I., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G. G., Higaki, K., & Kimura, T. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.013 · Cited by 510
Nanosuspensions for the Formulation of Poorly Soluble Drugs
Müller, R., Jacobs, C., & Kayser, O. (2000) · Drugs and the Pharmaceutical Sciences · doi:10.1201/b14005-13 · Cited by 501
Nanosuspensions for the formulation of poorly soluble drugs
Müller, R. H., & Peters, K. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00311-6 · Cited by 480
Cyclodextrins as Drug Carrier Molecule: A Review
Rasheed, A. (2008) · Scientia Pharmaceutica · doi:10.3797/scipharm.0808-05 · Cited by 394
Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms
Tang, B., Cheng, G., Gu, J.-C., & Xu, C.-H. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.04.006 · Cited by 393
Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs
Hu, J., Johnston, K. P., & Williams, R. O. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120030422 · Cited by 387
Mohammed, A. R., Weston, N., Coombes, A. G. A., Fitzgerald, M., & Perrie, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.010 · Cited by 386
Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation
Yang, T., Cui, F.-D., Choi, M.-K., Cho, J.-W., Chung, S.-J., Shim, C.-K., & Kim, D.-D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.011 · Cited by 385
Self-citationMicron‐Size Drug Particles: Common and Novel Micronization Techniques
Rasenack, N., & Müller, B. W. (2004) · Pharmaceutical Development and Technology · doi:10.1081/pdt-120027417 · Cited by 357
Preservation of freeze-dried liposomes by trehalose
Crowe, L. M., Crowe, J. H., Rudolph, A., Womersley, C., & Appel, L. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90498-9 · Cited by 351
Balakrishnan, P., Lee, B.-J., Oh, D. H., Kim, J. O., Hong, M. J., Jee, J.-P., Kim, J. A., Yoo, B. K., Woo, J. S., Yong, C. S., et al. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.03.001 · Cited by 346
Self-citationHecq, J., Deleers, M., Fanara, D., Vranckx, H., & Amighi, K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.014 · Cited by 339
Zhang, J. A., Anyarambhatla, G., Ma, L., Ugwu, S., Xuan, T., Sardone, T., & Ahmad, I. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.06.009 · Cited by 334
Watersoluble polymers in medicine
Bader, H., Ringsdorf, H., & Schmidt, B. (1984) · Die Angewandte Makromolekulare Chemie · doi:10.1002/apmc.1984.051230121 · Cited by 291
Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
Hu, L., Tang, X., & Cui, F. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044959 · Cited by 281
Das, S., Ng, W. K., Kanaujia, P., Kim, S., & Tan, R. B. H. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.07.036 · Cited by 274
Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs
Shin, H.-C., Alani, A. W. G., Rao, D. A., Rockich, N. C., & Kwon, G. S. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.024 · Cited by 243
Oral formulation strategies to improve solubility of poorly water-soluble drugs
Singh, A., Worku, Z. A., & Van den Mooter, G. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.606808 · Cited by 239
Estimating drug solubility in the gastrointestinal tract
Dressman, J. B., Vertzoni, M., Goumas, K., & Reppas, C. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.009 · Cited by 237
Pharmaceutical Technologies for Enhancing Oral Bioavailability of Poorly Soluble Drugs
Krishnaiah, Y. S. R. (2010) · Journal of Bioequivalence & Bioavailability · doi:10.4172/jbb.1000027 · Cited by 234
Yi, T., Wan, J., Xu, H., & Yang, X. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.001 · Cited by 209
Lee, S. C., Huh, K. M., Lee, J., Cho, Y. W., Galinsky, R. E., & Park, K. (2007) · Biomacromolecules · doi:10.1021/bm060307b · Cited by 206
Self-citationHan, X., Ghoroi, C., To, D., Chen, Y., & Davé, R. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.070 · Cited by 170
Patterson, J. E., James, M. B., Forster, A. H., Lancaster, R. W., Butler, J. M., & Rades, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.030 · Cited by 169
Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B
Yu, B. G., Okano, T., Kataoka, K., & Kwon, G. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00245-9 · Cited by 165
Liposome Formulation of Paclitaxel with Enhanced Solubility and Stability
Tao, Y., Cui, F., Choi, M., et al. (2007) · Drug Delivery · doi:10.1080/10717540601098799 · Cited by 145
Rogers, T. L., Johnston, K. P., & Williams, R. O. (2001) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100108363 · Cited by 138
Rogers, T. L., Nelsen, A. C., Hu, J., et al. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00063-2 · Cited by 134
Becket, G., Schep, L. J., & Tan, M. Y. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00382-2 · Cited by 133
Hu, J., Johnston, K. P., & Williams, R. O. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00203-3 · Cited by 127
Yan, Y.-D., Kim, J. A., Kwak, M. K., Yoo, B. K., Yong, C. S., & Choi, H. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1179 · Cited by 115
Self-citationDrug Carrier Systems for Solubility Enhancement of BCS Class II Drugs: A Critical Review
Kumar, S., Bhargava, D., Thakkar, A. R., & Arora, S. (2013) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2013005964 · Cited by 113
Direct Formation of Nanospheres from Amphiphilic β-Cyclodextrin Inclusion Complexes
Memiṣoǧlu, E., Bochot, A., Özalp, M., Şen, M., Duchêne, D., & Hıncal, A. A. (2003) · Pharmaceutical Research · doi:10.1023/a:1022263111961 · Cited by 101
Rogers, T. L., Nelsen, A. C., Sarkari, M., et al. (2003) · Pharmaceutical Research · doi:10.1023/a:1022628826404 · Cited by 97
Leuenberger, H., & Lanz, M. (2005) · Advanced Powder Technology · doi:10.1163/1568552053166683 · Cited by 70
The Effects of Lyophilization on the Physico-Chemical Stability of Sirolimus Liposomes
Ghanbarzadeh, S., Valizadeh, H., & Zakeri‐Milani, P. (2013) · Europe PMC (PubMed Central) · doi:10.5681/apb.2013.005 · Cited by 68
Recent advancements in mechanical reduction methods: particulate systems
Leleux, J. A., & Williams, R. O. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.828217 · Cited by 67
Onoue, S., Kojo, Y., Aoki, Y., et al. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rg-101 · Cited by 47
Cryogenic liquids, nanoparticles, and microencapsulation
Purvis, T., Vaughn, J. M., Rogers, T. L., Chen, X., Overhoff, K. A., Sinswat, P., Hu, J., McConville, J. T., Johnston, K. P., & Williams, R. O. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.04.012 · Cited by 43
Kumar, B. S., Saraswathi, R., Kumar, K. V., Jha, S. K., Venkatesh, D. P., & Dhanaraj, S. A. (2013) · Drug Delivery · doi:10.3109/10717544.2013.840690 · Cited by 37
Cited by
Biomedical Applications of Silver Nanoparticles: An Up-to-Date Overview
Burdușel, A.-C., Gherasim, O., Grumezescu, A. M., Mogoantă, L., Ficai, A., & Andronescu, E. (2018) · Nanomaterials · doi:10.3390/nano8090681 · Cited by 1,343
Yusuf, A., Almotairy, A. R. Z., Henidi, H., Alshehri, O. Y., & Aldughaim, M. S. (2023) · Polymers · doi:10.3390/polym15071596 · Cited by 914
Mesoporous silica nanoparticles for therapeutic/diagnostic applications
Jafari, S., Derakhshankhah, H., Alaei, L., Fattahi, A., Varnamkhasti, B. S., & Saboury, A. A. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.167 · Cited by 566
Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs
Censi, R., & Di Martino, P. (2015) · Molecules · doi:10.3390/molecules201018759 · Cited by 512
Molecular photoswitches in aqueous environments
Volarić, J., Szymanski, W., Simeth, N. A., & Feringa, B. L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00547a · Cited by 438
Metadata
- Authors
- Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J.
- Venue
- Asian Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 9
- Issue
- 6
- Pages
- 304-316
- ISSN
- 1818-0876 (ISSN-L)
- OpenAlex
- W2141566507
- Cited by
- 998
- References
- 65
- FWCI
- 30.42
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.